🔎 Trials Near Me

Utama › Kanser Prostat Rintangan Kastra › Michigan

Kajian klinikal Kanser Prostat Rintangan Kastra di Michigan

7 kajian untuk Kanser Prostat Rintangan Kastra sedang mencari peserta di lokasi di Michigan.

Bandar di Michigan

Teks kajian rasmi (Bahasa Inggeris)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Profound Research LLC at Cancer and Leukemia Center, Sterling Heights
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07225946

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • University of Michigan Health System, Ann Arbor
  • Henry Ford Cancer Detroit, Detroit
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 25 Sep 2026 · NCT07164443

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • START Midwest, Grand Rapids
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 24 Sep 2026 · NCT07719361

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

  • University of Michigan ( Site 0021), Ann Arbor
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06863272

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06242470

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

  • BAMF Health, Grand Rapids
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Lelaki · Dikemas kini 6 Mei 2026 · NCT04868604

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

  • Barbara Ann Karmanos Cancer Institute, Detroit
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Lelaki · Dikemas kini 13 Apr 2026 · NCT06190899

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.